Understanding the Role of Mineralocorticoid Receptor Antagonists and the Impact on Patient Care in Chronic Kidney Disease in Type 2 Diabetes

Gain expert insights on the evidence behind the use of finerenone in diabetic kidney disease selecting appropriate patients for finerenone therapy and strategies for overcoming clinical inertia.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bayer Healthcare Pharma